← Back
$GH All transactions

Guardant Health, Inc.

▼ SELL 10b5-1 Plan

$ Value

$19K

Shares

354

Price

$53

Filed

May 5

Insider

Name

Talasaz AmirAli

Title

Co-Chief Executive Officer

CIK

0001753159

Roles

Director Officer

Transaction Details

Transaction Date

2025-05-01

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

2,202,672

Footnotes

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2024. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.18 to $48.175 per shares, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.185 to $49.16 per shares, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.19 to $50.06 per shares, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.405 to $51.34 per shares, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.43 to $51.76 per shares, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.46 to $52.75 per shares, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.84 per shares, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Filing Info

Accession No.

0001576280-25-000141

Form Type

4

Issuer CIK

0001576280

Talasaz AmirAli's History

Date Ticker Type Value
2026-04-01 GH M $0
2026-04-01 GH M $0
2026-04-01 GH F $1.6M
2026-04-01 GH M $0
2026-04-01 GH M $0
2026-03-31 GH M $0
2026-03-31 GH F $132K
2026-03-31 GH M $0
2026-01-01 GH M $0
2026-01-01 GH F $1.1M

Other Insiders at GH (90d)

Insider Bought Sold Last
MIGNONE ROBERTO 2026-04-21
EAGLE CRAIG
Chief Medical Officer
2026-04-01
Monroe Terilyn J.
Chief People Officer
$355K 2026-04-06
Krognes Steve E. 2026-03-31
Bell Michael Brian
Chief Financial Officer
2026-04-01
Saia John G.
Chief Legal Officer
2026-04-15
Eltoukhy Helmy
Co-Chief Executive Officer
2026-04-01
Talasaz AmirAli
Co-Chief Executive Officer
2026-04-01
Hidalgo Medina Manuel 2026-04-17
Freeman Chris
Chief Commercial Officer
2026-04-01
Kalia Kumud
Chief Information Officer
2026-04-01
Tariq Musa $10K 2026-04-16
Chudova Darya
Chief Technology Officer
2026-04-01